Short-term clinical outcomes among patients undergoing transcatheter aortic valve implantation in Switzerland: the Swiss TAVI registry

EuroIntervention 2014;10:982-989 published online ahead of print April 2014. DOI: 10.4244/EIJV10I8A166

Peter Wenaweser
Peter Wenaweser1*, MD; Stefan Stortecky1, MD; Dik Heg2, PhD; David Tueller3, MD; Fabian Nietlispach4, MD; Volkmar Falk4, MD; Giovanni Pedrazzini5, MD; Raban Jeger6, MD; Oliver Reuthebuch6, MD; Thierry Carrel1, MD; Lorenz Räber1, MD; Franz W. Amann7, MD; Enrico Ferrari8, MD; Stefan Toggweiler9, MD; Stephane Noble10, MD; Marco Roffi10, MD; Jürg Gruenenfelder11, MD; Peter Jüni2, MD; Stephan Windecker1, MD; Christoph Huber
1. Department of Cardiology and Department of Cardiovascular Surgery, Swiss Cardiovascular Centre, Bern University Hospital, Bern, Switzerland; 2. Department of Clinical Research, Clinical Trials Unit, University of Bern, Bern, Switzerland; 3. Triemli Hos

Aims: To evaluate short-term clinical outcomes following transcatheter aortic valve implantation (TAVI) using CE-mark approved devices in Switzerland.

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

aortic stenosisoutcomestranscatheter aortic valve implantation
Read next article
The challenge of valve-in-valve procedures in degenerated Mitroflow bioprostheses and the advantage of using the JenaValve transcatheter heart valve

Latest news